scispace - formally typeset
Book ChapterDOI

Perioperative Evaluation and Management of Patients Undergoing Noncardiac Surgery

TLDR
This chapter outlines a systematic algorithm approach for cardiovascular risk assessment to guide perioperative strategies that may improve outcomes.
Abstract
Over 36 million patients undergo surgical procedures in the United States annually [1]. Around one-third of the patients undergoing surgeries have risk factors for or known cardiovascular disease [2]. The risk of perioperative cardiac complications is related to underlying cardiovascular disease burden [3]. Given the prevalence of cardiovascular disease, it is imperative for a practicing physician to perform an individualized evaluation of the surgical patient to provide an accurate preoperative risk assessment, risk stratification, and allow for modification of management strategies. This chapter outlines a systematic algorithm approach for cardiovascular risk assessment to guide perioperative strategies that may improve outcomes.

read more

Citations
More filters

Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery.

TL;DR: In this article, the authors examined the association between treatment with lipid-lowering medications and in-hospital mortality following major noncardiac surgery and found that using lipidlowering therapy was associated with lower crude mortality (2.13% vs 3.05%, P<.001).
References
More filters
Journal ArticleDOI

ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

TL;DR: It is important that the medical profession play a significant role in critically evaluating the use of diagnostic procedures and therapies as they are introduced in the detection, management, and management of diseases.
Journal ArticleDOI

Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery

TL;DR: In patients with severe aortic stenosis who were not suitable candidates for surgery, TAVI, as compared with standard therapy, significantly reduced the rates of death from any cause, the composite end point of deathFrom any cause or repeat hospitalization, and cardiac symptoms, despite the higher incidence of major strokes and major vascular events.
Journal ArticleDOI

2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk

TL;DR: The ACC and AHA have collaborated with the National Heart, Lung, and Blood Institute and stakeholder and professional organizations to develop guidelines, standards, and policies that promote optimal patient care and cardiovascular health.
Related Papers (5)